When classified according to previous treatment before tumor sampling, patients who received immunotherapy (e.g., IFNα, DC vaccine, or ICP blocker) displayed significantly higher proportions of iNKT cells (among CD45+ cells or CD3+ T cells) infiltrating the tumor (Figure 2C), revealing that immunotherapy may enhance iNKT cell recruitment to the tumor site. Here, PTPRC is linked to neoplasm.